Drug & Medication

Summary

Table of Contents

  • Publication date: December 2011
Keywords : Drug , Pregabalin, morphine, ropivacaine, oxycodone, Tramadol, Fentanyl, Lornoxicam, Naproxen

Norway Anesthesia and Respiratory Devices Investment Opportunities, Analysis and Projections to 2017 ”Norway Anesthesia and Respiratory Devices Investment Opportunities, Analysis and Projections to 2017”, a new report by Global Industries Direct, provides key industry data on the Norway Anesthesia and Respiratory Devices industry . The report provides value (USD million), volume (units) and average price (USD) data for each sector and...

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Robyn

00 1 718 213 49 04

Send Your Request

Share

Global Drug And Medication Industry : Latest Reports

Ahn-Gook Pharmaceutical Co., Ltd. (Symbol:001540) SWOT Analysis, Strategy, Revenues and Profits

Ahn-Gook Pharmaceutical Co., Ltd. (Symbol:001540) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Jiangsu Hengrui Medicine Co., Ltd. (Symbol:600276) SWOT Analysis, Strategy, Revenues and Profits

Jiangsu Hengrui Medicine Co., Ltd. (Symbol:600276) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Ambalal Sarabhai Enterprises Limited (Symbol:500009) SWOT Analysis, Strategy, Revenues and Profits

Ambalal Sarabhai Enterprises Limited (Symbol:500009) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...


Global Drug And Medication Industry : Latest Downloads

Company Report: Drug for Year 2012

Company Report: Drug for Year 2012

  • Company report
  • April 2012
  • 6 pages

... Impact to the sector S valuation and earnings outlook, as none of the hk-listed pharmaceutical companies are in the investigation list. Based on the location of these nine drug-makers, we believe ...

Company Report: Drug and Medication for Year 2012

Company Report: Drug and Medication for Year 2012

  • Company report
  • March 2012
  • 74 pages
  • by Corporation

... Position, we raise our target price fro are and upgrade the stock from hold to ment discipline, resulting from the lack -subsidized drugs, as well as increasi rketing expenses), continues to bite ...

Company Report: Drug and Medication for Year 2012

Company Report: Drug and Medication for Year 2012

  • Company report
  • March 2012
  • 12 pages

... M hospital drugs. This budget came under pressure during 2011/12 through a step increase in demands for certain drugs known as anti tnf and biologics, used predominantly in rheumatology ...


Related Market Segments :

Anesthetics
Analgesic
Cold Medicine
Drug
Lidocaine

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.